XML 88 R57.htm IDEA: XBRL DOCUMENT v3.7.0.1
Acquisitions (Schedule of Estimated Fair Values of the Assets Acquired and Liabilities Assumed) (Details) - USD ($)
$ in Millions
12 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Oct. 02, 2015
Aug. 26, 2015
Jul. 02, 2015
Jun. 30, 2015
Business Acquisition [Line Items]            
Goodwill $ 7,221 $ 7,167       $ 5,070
Customer relationships | Minimum            
Business Acquisition [Line Items]            
Weighted average used lives of intangibles 4 years          
Customer relationships | Maximum            
Business Acquisition [Line Items]            
Weighted average used lives of intangibles 13 years          
Trade names | Minimum            
Business Acquisition [Line Items]            
Weighted average used lives of intangibles 10 years          
Trade names | Maximum            
Business Acquisition [Line Items]            
Weighted average used lives of intangibles 20 years          
Developed technology            
Business Acquisition [Line Items]            
Weighted average used lives of intangibles 10 years          
Cordis            
Business Acquisition [Line Items]            
Total identifiable intangible assets acquired     $ 800      
Cash and equivalents     0      
Trade receivables     0      
Inventories     205      
Prepaid expenses and other     4      
Property and equipment     97      
Other assets     44      
Accounts payable     (82)      
Other accrued liabilities     (85)      
Deferred income taxes and other liabilities     (13)      
Redeemable noncontrolling interests     0      
Total identifiable net assets/(liabilities) acquired     970      
Goodwill     914      
Total net assets acquired     1,884      
Cordis | In-process research and development            
Business Acquisition [Line Items]            
Indefinite-lived intangible assets     55      
Cordis | Customer relationships            
Business Acquisition [Line Items]            
Finite-lived intangible assets     225      
Cordis | Trade names            
Business Acquisition [Line Items]            
Finite-lived intangible assets     125      
Cordis | Developed technology            
Business Acquisition [Line Items]            
Finite-lived intangible assets     $ 395      
naviHealth            
Business Acquisition [Line Items]            
Total identifiable intangible assets acquired       $ 115    
Cash and equivalents       53    
Trade receivables       31    
Inventories       0    
Prepaid expenses and other       14    
Property and equipment       5    
Other assets       1    
Accounts payable       (2)    
Other accrued liabilities       (95)    
Deferred income taxes and other liabilities       (33)    
Redeemable noncontrolling interests       (119)    
Total identifiable net assets/(liabilities) acquired       (30)    
Goodwill       321    
Total net assets acquired       291    
naviHealth | In-process research and development            
Business Acquisition [Line Items]            
Indefinite-lived intangible assets       0    
naviHealth | Customer relationships            
Business Acquisition [Line Items]            
Finite-lived intangible assets       38    
naviHealth | Trade names            
Business Acquisition [Line Items]            
Finite-lived intangible assets       16    
naviHealth | Developed technology            
Business Acquisition [Line Items]            
Finite-lived intangible assets       $ 61    
Harvard Drug            
Business Acquisition [Line Items]            
Total identifiable intangible assets acquired         $ 600  
Cash and equivalents         44  
Trade receivables         67  
Inventories         49  
Prepaid expenses and other         11  
Property and equipment         16  
Other assets         0  
Accounts payable         (47)  
Other accrued liabilities         (37)  
Deferred income taxes and other liabilities         (188)  
Redeemable noncontrolling interests         0  
Total identifiable net assets/(liabilities) acquired         515  
Goodwill         634  
Total net assets acquired         1,149  
Harvard Drug | In-process research and development            
Business Acquisition [Line Items]            
Indefinite-lived intangible assets         0  
Harvard Drug | Customer relationships            
Business Acquisition [Line Items]            
Finite-lived intangible assets         470  
Harvard Drug | Trade names            
Business Acquisition [Line Items]            
Finite-lived intangible assets         130  
Harvard Drug | Developed technology            
Business Acquisition [Line Items]            
Finite-lived intangible assets         $ 0